Edgestream Partners, L.P. Merck & Co., Inc. Transaction History

Edgestream Partners, L.P.

$2.88 Billion
Q1 2025

A detailed history of Edgestream Partners, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 30,158 shares of MRK stock, worth $2.33 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

30,158

Previous 7,895 281.99%

Holding current value

$2.33 Million

Previous $785,000 244.71%

% of portfolio

0.09%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$83.01 - $101.02 $1.85 Million - $2.25 Million	22,263 Added 281.99%	30,158 $2.71 Million
Q4 2024 Feb 06, 2025	SELL	$96.31 - $114.76 $1.26 Million - $1.5 Million	-13,101 Reduced 62.4%	7,895 $785,000
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $1.25 Million - $1.45 Million	11,246 Added 115.34%	20,996 $2.38 Million
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $1.21 Million - $1.3 Million	9,750 New	9,750 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $358,043 - $389,637	3,574 Added 40.72%	12,351 $1.35 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $535,134 - $594,287	5,198 Added 145.24%	8,777 $903,000
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $55,825 - $60,847	-514 Reduced 12.56%	3,579 $412,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $369,451 - $412,232	-3,589 Reduced 46.72%	4,093 $435,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $40,309 - $51,682	-461 Reduced 5.66%	7,682 $852,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $688,327 - $773,259	8,143 New	8,143 $701,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $4.47 Million - $5.07 Million	-53,582 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $2.7 Million - $3.02 Million	-36,707 Reduced 40.66%	53,582 $4.4 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $4.57 Million - $5.72 Million	63,222 Added 233.58%	90,289 $6.92 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $1.36 Million - $1.49 Million	18,905 Added 231.62%	27,067 $2.03 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $9.02 Million - $9.98 Million	-128,324 Reduced 94.02%	8,162 $635,000
Q1 2021 May 06, 2021	BUY	$68.86 - $81.11 $1.66 Million - $1.95 Million	24,058 Added 21.4%	136,486 $10.5 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $8.07 Million - $8.95 Million	112,428 New	112,428 $9.2 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $321,171 - $445,159	-5,069 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $5.35 Million - $6.04 Million	-68,990 Reduced 93.16%	5,069 $461,000
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $3.43 Million - $3.74 Million	-45,120 Reduced 37.86%	74,059 $6.23 Million
Q2 2019 Aug 08, 2019	BUY	$69.84 - $81.59 $4.25 Million - $4.97 Million	60,864 Added 104.37%	119,179 $9.99 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $4.06 Million - $4.63 Million	58,315 New	58,315 $4.85 Million

Others Institutions Holding MRK

# of Institutions

3,891

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $195B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Merck & Co., Inc. Transaction History